'Artificial pancreas' aids blood-glucose control in diabetics
An ’artificial pancreas’ has allowed diabetic patients to better control their blood-glucose levels in a recent clinical trial.

The system uses a small subcutaneous patch to continuously monitor glucose levels, sending the results via radio frequency to a small computer that calculates the appropriate insulin dose, which is then delivered by a insulin pump.
‘The system has the potential to improve the safety and effectiveness of insulin delivery and may allow more flexible lifestyles in the future,’ said Dr Roman Hovorka of Cambridge University, who led the study.
He added that it could be particularly useful when worn at night, since this is the time when most patients experience potentially dangerous blood-sugar drops — or hypoglycemic events — which are also exacerbated by alcohol consumption.
The conventional approach to diabetes monitoring and treatment is based around finger-prick testing combined with daily insulin injections that are adjusted accordingly by the patient with help from health workers.
In recent years, several technologies have started to come through to help patients better manage their condition around their daily activities.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
The EU and UK will be moving towards using Grid Forming inverters with Energy Storage that has an inherent ability to act as a source of Infinite...